✦ LIBER ✦

Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas

✍ Scribed by Donnie R. Stacy; Kim Ely; Pierre P. Massion; Wendell G. Yarbrough; Dennis E. Hallahan; Konjeti R. Sekhar; Michael L. Freeman

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 176 KB
Volume: 28
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.20430

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

Head and neck squamous cell carcinoma (HNSCC) continues to cause significant morbidity and mortality. Overexpression of specific phase II gene products may represent an important biomarker. One regulator of phase II gene expression is the transcription factor nuclear factor E2 p45‐related factor 2 (Nrf2). Nrf2 expression was evaluated in HNSCC, to determine whether it might serve as a biomarker for early detection of disease.

Methods.

A tissue microarray was constructed of 141 HNSCC biopsy cores from 47 HNSCCs. In addition, histologically normal squamous mucosa was obtained from 7 patients. Protein expression was evaluated by immunohistochemistry.

Results.

Nrf2 expression was increased in 91.5% of tumors. Expression of thioredoxin, a Nrf2‐reguated gene product, was elevated in 75% of tumors. Keap1, which regulates the rate of Nrf2 ubiquitination and degradation, was relatively overexpressed in HNSCC compared with normal mucosa.

Conclusions.

📜 SIMILAR VOLUMES

Clinical significance ofEphA2expression

Clinical significance ofEphA2expression in squamous-cell carcinoma of the head and neck

✍ Yong Liu; Xin Zhang; Yuanzheng Qiu; Donghai Huang; Shuai Zhang; Li Xie; Lin Qi; 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 618 KB

Bcl-xL and Bcl-2 expression in squamous

Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck

✍ John C. Pena; Craig B. Thompson; Wendy Recant; Everett E. Vokes; Charles M. Rudi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 2 views

## Background: Inhibition of apoptosis, or programmed cell death, may be critical both in the development of cancer and in determining response to therapy. the authors examined the expression of two related apoptotic inhibitors, bcl-2 and bcl-xl, in pretreatment biopsies from a series of 42 patient

Vascular endothelial growth factor C and

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck

✍ Csilla Neuchrist; Bohan M. Erovic; Allesandra Handisurya; Michael B. Fischer; Ge 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 1 views

## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (flt‐4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph

Glutamate is a determinant of cellular p

Glutamate is a determinant of cellular proliferation through modulation of nuclear factor E2 p45-related factor-2 expression in osteoblastic MC3T3-E1 cells

✍ Kyosuke Uno; Takeshi Takarada; Eiichi Hinoi; Yukio Yoneda 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

## Abstract Activation of particular glutamate (Glu) receptors is shown to promote cellular differentiation toward maturation during osteoblastogenesis. In the present study, we have evaluated the possible modulation by Glu of cellular proliferation in osteoblastic cells endowed to proliferate for

Mutation of p53 in head and neck squamou

Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis

✍ Genevieve A. Andrews; Sichuan Xi; Rebecca G. Pomerantz; Charles J. Lin; William 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

## Abstract ## Background. The p53 protein, a well‐known tumor suppressor that functions primarily as a transcription factor, initiates cell cycle arrest and apoptosis after genotoxic stress. The antiapoptotic regulator Bcl‐2 is a downstream modulator of p53‐induced apoptosis. Loss of function of

Effects of p53 or p27 overexpression on

Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines

✍ Dong Wook Lee; Seok-Woo Park; Soo-Yeun Park; Dae-Seog Heo; Kwang Hyun Kim; Myung 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

## Abstract ## Background. Although cyclooxygenase‐2 (COX‐2) has been suggested to play an important role in carcinogenesis, the effects of tumor suppressors on COX‐2 gene expression and the combined antitumor effects of tumor suppressors and COX‐2 inhibitors have rarely been investigated. ## Met